Hospitals in China Begin Clinical Trials of Surgical Robots in Gynecology

Robotic surgery is an advanced procedure that allows doctors and surgeons to perform complex surgeries through the help of surgical robots or robot assistance. It allows doctors and surgeons to operate with heightened precision and accuracy, which reduces the surgical trauma of the patient being operated on and gives them a faster healing period.

Edge Medical Robotics Co., Ltd., a surgical robot platform company based in Shenzhen, China, has developed an endoscopic surgical robot that can help in assisting specially trained doctors to perform complex procedures and operations in the field of gynecology.

The China-developed endoscopic surgical robot to assist in gynecological operations is a major breakthrough in both medical technology and the domestic surgical robot industry.

Clinical trials for these highly specialized robot-assisted operations are only being rolled out in the field of gynecology and obstetrics for the time being. The select hospitals beginning these surgical robot clinical trials are The Chinese People’s Liberation Army (PLA) General Hospital in Beijing and the First Affiliated Hospital of Zhengzhou University in central China’s Henan Province.

The Future of China’s Domestic Surgical Robots Industry

With the development of domestic surgical robots by Edge Medical, Ji Mei, a gynecologist in the First Affiliated Hospital, is hopeful that it can greatly impact the potential for primary hospitals to start carrying it out as it is more cost-effective than its foreign counterparts.

The director of the gynecological department of Chinese PLA General Hospital, Meng Yuanguang, shares the same sentiment as Ji Mei. Meng Yuanguang shares how crucial these self-developed domestic surgical robots can be in providing higher quality medical services in primary hospitals for patients.

Although Wang Jianchen, the CEO of Edge Medical Robotics Co., Ltd., points out how there is still a delay in the development of technology and surgical robots in China due to factors such as high costs, limited implementation in few hospitals and departments, and longtime foreign competitors dominating the field, this may also indicate the growth potential of their domestic surgical robots industry once these impediments have been solved.

On that note, Business Wire reported that China’s Medical Robot Industry will be worth $2.49 billion by 2026. Should the clinical trials of these self-developed domestic surgical robots be a success, we may look at more robotic surgeries to be developed and rolled out in other fields and departments at primary hospitals in China. As a result, this can possibly contribute more to the estimated figure, but more importantly, provide top-notch medical services that are highly accessible to the public.